{
    "2021-03-09": [
        [
            {
                "time": "",
                "original_text": "国开证券---医药行业点评报告：2月疫苗行业批签发数据点评【行业研究】",
                "features": {
                    "keywords": [
                        "疫苗",
                        "批签发",
                        "医药行业"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "山西证券---医药生物行业：2020年疫苗批签发数据跟踪，行业景气度持续，热门大品种快速放量【行业研究】",
                "features": {
                    "keywords": [
                        "疫苗",
                        "批签发",
                        "行业景气度",
                        "热门品种"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物跌7.5% 上月初申银万国研报喊买",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "股价下跌",
                        "研报"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：逐步布局一季报高增长核心资产",
                "features": {
                    "keywords": [
                        "医药行业",
                        "一季报",
                        "高增长",
                        "核心资产"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国盛证券---医药生物行业周报：全民免疫迫在眉睫，新冠疫苗的热点问题怎么看【行业研究】",
                "features": {
                    "keywords": [
                        "全民免疫",
                        "新冠疫苗",
                        "热点问题"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "西南证券---医药行业周报：核心资产性价比在提升，同时关注PEG投资机会【行业研究】",
                "features": {
                    "keywords": [
                        "核心资产",
                        "性价比",
                        "PEG",
                        "投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业半月谈：医药行业估值性价比开始凸显 适时布局高景气赛道和高成长个股",
                "features": {
                    "keywords": [
                        "医药行业",
                        "估值性价比",
                        "高景气赛道",
                        "高成长个股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}